Salomon Stavchansky, Ph.D.
ICD2 Conference Scientific Chair
Professor of Pharmaceutics
UT Austin College of Pharmacy
Salomon A. Stavchansky, Ph.D., received his B.Sc. degree in Pharmacy from The National Autonomous University of Mexico (Suma cum laude) in 1969, and his Ph.D. in Pharmaceutical Sciences from the University of Kentucky at Lexington in 1974. Dr. Stavchansky’s research at Sloan-Kettering Institute for Cancer Research involved the synthesis of carbon-II phenytoin with the purpose of following the in vivo distribution of phenytoin and the identification of gliomas and neuroblastomas. Dr. Stavchansky worked as an analytical chemist at the National Medical Center in Mexico where he helped develop an immunofluorescence antibody diagnostic test for toxoplasmosis. In 1968 he joined the research and development group of Syntex Laboratories developing steroidal formulations. Dr. Stavchansky joined the University of Texas in 1974 where he was awarded the Teaching Excellence Award and has received the Alfred and Dorothy Mannino Fellowship in Pharmacy, the James T. Doluisio Centennial Fellowship, and is now holder of the Alcon Centennial Professorship.
Dr. Stavchansky recently served as an ad-hoc member in the Clinical Pharmacology and Pharmaceutical Sciences Advisory Committee of the Food and Drug Administration. Dr Stavchansky is a fellow of the American Association of Pharmaceutical Scientists (AAPS), an expert member of the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP). Corresponding Member of the National Academy of Pharmaceutical Sciences of Mexico, Corresponding Member of the National Academy of Pharmaceutical Sciences of Chile, Honorary member of the Mexican Pharmaceutical Association, Honorary Member of the United States Pharmacopeial Convention, and has served as advisor and external tutor of The Council of Science and Technology of Mexico. The jury presided by the President of the Commission of Honor and Justice of the Colegio Nacional de Químico Farmacéuticos Biólogos of Mexico, the oldest pharmacy guild in Mexico, recently awarded Dr. Stavchansky the Recognition to Pharmaceutical Excellence in the category of Professional Trajectory in Research and Education. Dr. Stavchansky presently served as Chair of the International Health Committee and served as a member of the Executive Committee of the Council of Experts of the United States Pharmacopeia (USP), Chair of the USP Expert Committee on Bioavailability and Nutrients Absorption and member of the Policy Committee of the USP. He recently served on the Advisory Committee to the Office of Generic Drugs and on the Pharmaceutical Science Advisory Committee of the Food & Drug Administration. Dr. Stavchansky was a member of the review committee on drug delivery systems for The National Institute of Child Human Development and The National Institute on Drug Abuse and served as an ad-hoc reviewer for the National Institute of Health and reviewer for NIH Small Business Grants. Dr. Stavchansky served in the expert panel of the World Health Organization and the Pan American Health Organization (PANHDRA) in the area of bioavailability and bioequivalence drugs and biologics. He served as a special advisor to the National Agency of Sanitary Vigilance in Brazil during the drafting of the regulation of generic drug products. Dr. Stavchansky was also a member of the Bioavailability Steering Committee of the American Pharmaceutical Association. He served as Chairman of the Translation Committee of the USP into Spanish.
Dr. Stavchansky presently serves in The University of Texas at Austin Policy Committee on Promoting Objectivity in Research Managing, Reducing or Eliminating Financial Conflict of Interest, and served in the Faculty Council, the Budget Committee, the Graduate Assembly, the Academic Committee of the Graduate Assembly, and the Committee for International Studies
Dr. Stavchansky has directed and participated in research concerning: 1) the development of analytical methodology for the measurement of drugs in biological fluids, the absorption, metabolism, distribution, and elimination of drugs from biological fluids in animals and man, and the evaluation and design of drug delivery systems, 2) the link of solubility, permeability, and drug transport through biological membranes, and 3) the conduct morphometric studies of the intestinal epithelium to elucidate the effect of formulation excipients.
Presently, Dr. Stavchansky’s research group is exploring cytoprotection from oxidative stress at the molecular level, 2) integration of system biology to pharmacodynamics and pharmacokinetics, and 3) targeted nano-delivery of drugs. Dr Stavchansky continues his research efforts in the area of generic drugs and biosimilars. This work has resulted in over 150 publications, more than 270 national and international presentations and two book chapters. Dr. Stavchansky has supervised and contributed to dissertations, theses, and reports for many Master and Ph.D. students.
Dr. Stavchansky has served on the ICD2 planning committee since 1974, and has served as the Conference Scientific Chair since 1987.
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
